2027년 3월 3일
FDA PDUFA target action date for zanzalintinib + atezolizumab, a NDA from Exelixis. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA 결정 날짜 캘린더